BioTime, Inc. (BTIM.OB)


BioTime, headquartered in Emeryville, California, develops blood plasma volume expanders, blood replacement solutions for hypothermic (low temperature) surgery, organ preservation solutions, and technology for use in surgery, emergency trauma treatment and other applications. BioTime's lead product Hextend is manufactured and distributed in the U.S. by Hospira, Inc. and in South Korea by CJ Corp. under exclusive licensing agreements. Information about BioTime can be found on the web at

Contact Information

6121 Hollis Street
Emeryville, CA 94608

tel: 510-350-2940
fax: 510-350-2948


Investor Relations



Exchange: OTCBB
Industry: Biotechnology
Market Cap: $11.5M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.